Giant desmoplastic small round cell tumor of the abdomen: A case report

Desmoplastic small round cell tumor (DSRCT) is a rare, aggressive, mesenchymal malignancy of a separate clinicopathological entity. It has a predilection for young men, with no evidence of any ethnic predilection. The current diagnostic gold standard for DSRCT includes histopathologic, immunohistoch...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 12; p. 992346
Main Authors Wang, Wuke, Chen, Yunjie, Wang, Chunnian, Su, Hui
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 22.11.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Desmoplastic small round cell tumor (DSRCT) is a rare, aggressive, mesenchymal malignancy of a separate clinicopathological entity. It has a predilection for young men, with no evidence of any ethnic predilection. The current diagnostic gold standard for DSRCT includes histopathologic, immunohistochemical, and cytogenetic studies in order to confirm the variable phenotypic expression and characteristic chromosomal translocation. A 65-year-old man presented with a sensation of an abdominal mass and a presentation of an incomplete bowel obstruction. Initial lab tests were in the normal range except for carbohydrate antigen. Contrast-enhanced CT showed that a large, mass-confounding density was occupied in the omentum majus area of the middle and lower abdominal wall. A 3D reconstruction of the images was performed to clarify the relationship between the tumor and the colon and was confirmed by a colonoscopy. After surgery, immunohistochemistry and fluorescence hybridization (FISH) revealed EWSR1-WT1 gene rearrangement at 22q12, confirming the diagnosis of desmoplastic small round cell tumor. Being different from the predilection of DSRCT for young men, the patient in our case is a 65-year-old man with a huge mass involving the transverse colon and the bladder.
Bibliography:This article was submitted to Surgical Oncology, a section of the journal Frontiers in Oncology
Edited by: Aali Jan Sheen, Manchester Royal Infirmary, United Kingdom
Reviewed by: Ayman Zaki Azzam, Alexandria University, Egypt; Rahul Gupta, Synergy Institute of Medical Sciences, India
ORCID: Wuke Wang, orcid.org/0000-0001-8477-5900; Hui Su, orcid.org/0000-0002-6897-3621
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2022.992346